| Title |
Complement inhibitor eculizumab in thrombotic microangiopathy: single-center case series / |
| Authors |
Vitkauskaitė, Monika ; Vinikovas, Artūras ; Miglinas, Marius ; Rimševičius, Laurynas ; Čerkauskaitė, Agnė ; Mačionienė, Ernesta ; Ašakienė, Eglė |
| DOI |
10.1002/ccr3.5573 |
| Full Text |
|
| Is Part of |
Clinical case reports.. Hoboken : Wiley-Blackwell Publishing Ltd. 2022, vol. 10, no. 3, p. 5573-5581.. ISSN 2050-0904 |
| Keywords [eng] |
atypical hemolytic uremic syndrome ; complement ; eculizumab ; nephrology ; thrombotic microangiopathy |
| Abstract [eng] |
Our case series showed that eculizumab is efficacious and safe in treating thrombotic microangiopathy, as well as it has positive effects on quality of life. Further extensive studies are required to develop unified treatment guidelines. |
| Published |
Hoboken : Wiley-Blackwell Publishing Ltd |
| Type |
Journal article |
| Language |
English |
| Publication date |
2022 |
| CC license |
|
